Albert Osterhaus | |
---|---|
Born | Albertus Dominicus Marcellinus Erasmus Osterhaus 2 June 1948 Amsterdam, Netherlands |
Alma mater | Utrecht University (MSc and PhD) |
Known for | Identification of SARS coronavirus SARS drug Vaccine for H5N1 |
Awards | M.W. Beijerinck Award Louis D. Grand Prize |
Scientific career | |
Fields | Virology |
Institutions | TiHo Hannover |
Doctoral advisor | Marian Horzinek |
Albertus Dominicus Marcellinus Erasmus "Ab" Osterhaus (born 2 June 1948) is a leading Dutch virologist and influenza expert. An Emeritus Professor of Virology at Erasmus University Rotterdam since 1993, Osterhaus is known throughout the world for his work on SARS and H5N1, the pathogen that causes avian influenza.
Osterhaus was born into a Roman Catholic family of seven and grew up in Slotermeer, Amsterdam. From 1967 he studied at the Utrecht University where he graduated with a degree in veterinary medicine cum laude in 1974. He then obtained his PhD degree at the same university in 1978 with a dissertation entitled Feline infectious peritonitis: identification, propagation and epidemiology.
He fulfilled several positions in his 16-year career at the Netherlands National Institute for Public Health and the Environment (RIVM) in Bilthoven, the last of which was head of the laboratory for Immunobiology. During that period he was also a part-time Professor of Environmental Virology at the Institute for Virology in Utrecht, a position he still holds as of 2009. In 1993, he became Professor of Virology at the Medical Faculty of University and also head of the Department of Virology at Erasmus University Medical Centre Rotterdam. In 2013, he stepped down from his position as head of the department of Viroscience, as the Virology department is now known, and handed over the reins to Professor Marion Koopmans, formerly attached to the Dutch National Institute of Health, the RIVM. Osterhaus did not rest and set up a new institute looking at the zoonotic side of virology at TiHo in Hannover, Germany. He also holds a position at Artemis BV in Utrecht.
Osterhaus played an important role in the identification of the SARS coronavirus. In February 2004, his team found that Pegylated interferon alpha, a drug used for the treatment of patients with Hepatitis C, helps combat the virus that causes SARS.
Osterhaus holds various editorial positions for scientific journals, holds several patents, has been supervisor of more than 40 PhD students and has identified more than a dozen “new” viral pathogens [1] and he is author of more than 1000 scientific papers, including journals like Nature , Science and The Lancet . [2] Osterhaus served as member and chairman of many international scientific committees, most notably four WHO reference centres, the Dutch Influenza Centre, the Dutch Health Council and the European Scientific Working group on Influenza (ESWI).
Osterhaus received several awards in his life, including the Dutch "M.W. Beijerinck Virology Award", a prize awarded triennially (before 2014, and now awarded biennially) by the Royal Netherlands Academy of Arts and Sciences in 1998. [3] He is also a Member of Royal Netherlands Academy of Arts and Sciences (KNAW) since 2001. [4]
On 15 October 2003 Osterhaus was knighted as Commander in the Order of the Dutch Lion. [1] Other awards Osterhaus received include the Dutch "Dr. Saal van Zwanenberg Prijs" for pharmacotherapy, [5] the "Reinier de Graaf Medaille" [6] for clinical medicine, and on 13 June 2007 he was awarded the French "Grand Prix scientifique de la Fondation Louis D." of the Institut de France. He shared the €450,000 prize money with National Institute for Medical Research professor Sir John Skehel from London. [7] In 2016 he became a member of the German Academy of Sciences Leopoldina. [8]
Osterhaus has been criticised for what has been described as a 'fear campaign', for exaggerating the consequences of the 2009 flu pandemic and pushing for extensive measures, even though the pandemic influenza (H1N1) is now treated as if it were a common flu. Physician and microbiologist Miquel Ekkelenkamp called Osterhaus a 'scaremonger' in an opinion piece in nrc.next and said: "'Expert' Osterhaus should be banned indefinitely from television. Everything he claimed turned out to be untrue: we're not all going to die like we did in 1918, not everyone needs a vaccination, we are not going to give Tamiflu to everyone and the virus has not mutated into something much more dangerous." [9] Osterhaus claimed he has not exaggerated the risks. During debate 'De Kwestie live' he said "I have named a wide spectrum of possibilities and minister Ab Klink decided to go for the worst-case scenario" [9] [10]
In September 2009, a controversy arose when it became known Osterhaus has a 9.8% share in ViroClinics B.V, a pharmaceutical company that supposedly benefits from the 34 million vaccines Health minister Ab Klink bought based on his advice as government consultant. Osterhaus maintains he did nothing against the law and that he does not personally benefit from the order.
Martinus Willem Beijerinck was a Dutch microbiologist and botanist who was one of the founders of virology and environmental microbiology. He is credited with the discovery of viruses, which he called "contagium vivum fluidum".
Erasmus University Rotterdam is a public research university located in Rotterdam, Netherlands. The university is named after Desiderius Erasmus Roterodamus, a 15th-century humanist and theologian.
The National Institute for Public Health and the Environment is a Dutch research institute that is an independent agency of the Ministry of Health, Welfare and Sport.
Erasmus University Medical Center based in Rotterdam, Netherlands, affiliated with Erasmus University and home to its faculty of medicine, is the largest and one of the most authoritative scientific University Medical Centers in Europe. The hospital is the largest of the eight university medical centers in the Netherlands, both in terms of turnover and number of beds. The Erasmus MC ranks #1 of the top European institution in clinical medicine and #20 in the world according to the Times Higher Education rankings.
Sir John James Skehel, is a British virologist and Emeritus scientist at the Francis Crick Institute in London. From 1987 to 2006 he was director of the National Institute of Medical Research (NIMR) at Mill Hill which was incorporated into the Crick Institute in 2016.
Peter Palese is a United States microbiologist, inventor, professor, and chair of the Department of Microbiology at the Icahn School of Medicine at Mount Sinai in New York City, and an expert in the field of RNA viruses.
Everhardus Jacobus Ariëns was a Dutch pharmacologist and professor at the Catholic University of Nijmegen. He made important contributions to the function of receptors and the mathematical description of ligand–receptor interactions. Moreover, Everhardus Ariëns was the initiator for the collection of stereochemistry in drug development and spearheading the development of enantiopure drugs.
Monique Maria Bernadette Breteler is a Dutch neuroepidemiologist. She is Director of Population Health Sciences at the German Center for Neurodegenerative Diseases (DZNE), Professor of Population Health Sciences at the University of Bonn, and Adjunct Professor of Epidemiology at the Harvard School of Public Health in Boston, Massachusetts. She has been a foreign member of the Royal Netherlands Academy of Arts and Sciences since 2015.
Josina Maria "Jozien" Bensing is a Dutch clinical psychologist. Bensing was director of the Nederlands Instituut voor Onderzoek van de Gezondheidszorg (NIVEL) between 1985 and 2008. Since 1993 she has been a professor of clinical and healthcare psychology at Utrecht University. Bensing was a winner of the 2006 Spinoza Prize.
Ralf F. W. Bartenschlager is a German virologist who has been researching hepatitis C since 1989. He is a professor in the Department of Infectious Diseases at the Heidelberg University.
Marcus Alphons Petrus"Mark"Bovens is a Dutch scholar of public administration. He has been professor of public administration at Utrecht University since 2000. Bovens has been a member of the Scientific Council for Government Policy since 2013.
Jan Luiten van Zanden is a Dutch economic historian and professor of Global Economic History at Utrecht University. He is a widely acknowledged specialist in Dutch, European and Global Economic History.
Louis (Wiep) van Bunge is a Dutch historian of philosophy. He has published mainly on the early Enlightenment in the Netherlands, on Spinoza and on his influence on other thinkers.
Wiro J. Niessen is a Dutch scientist in biomedical image analysis and machine learning. He is full professor at both Erasmus MC, University Medical Center Rotterdam and Delft University of Technology. He is founder and scientific lead of Quantib, an AI company in medical imaging. In 2015 he received the Simon Stevin Meester Award from the Netherlands Organization for Scientific Research. From 2016 to 2019 he was president of the Medical Image Computing and Computer Assisted Interventions Society. In 2017 he was elected to The Netherlands Royal Academy of Arts & Sciences. He is director of the AI platform of the European Organization for Biomedical Imaging Research.
Maria Petronella Gerarda Koopmans is a Dutch virologist who is Head of the Erasmus MC Department of Viroscience. Her research considers emerging infectious diseases, noroviruses and veterinary medicine. In 2018 she was awarded the Netherlands Organisation for Scientific Research (NWO) Stevin Prize. She serves on the scientific advisory group of the World Health Organization.
Albert"Ab"van Kammen is a Dutch molecular biologist and virologist. He was a professor of molecular biology at Wageningen University and Research between 1972 and 1996.
Bob Löwenberg is a clinical hematologist/investigator. He is Professor of Hematology at Erasmus University Rotterdam.
Ronaldus (Ron) Adrianus Maria Fouchier is a Dutch virologist who is Deputy head of the Erasmus MC Department of Viroscience, headed by Prof. Marion Koopmans.
The M.W. Beijerinck Virology Prize is a prize in virology awarded every two years by the Koninklijke Nederlandse Akademie van Wetenschappen (KNAW). The prize consists of a medal and a monetary award of €35,000. KNAW's two conditions for the prize nomination are that the nominee must be an internationally recognized researcher who has "made a groundbreaking contribution to research in the field of virology in the broadest sense" and must have an appointment at a university or research institute.